Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma. (nejm.org)

Authors: Costa LJ … Mateos MV Journal: New England Journal of Medicine Published: 2026-02-19 DOI: https://doi.org/10.1056/NEJMoa2514663